Comparison of the efficacy and safety of pulmonary vein cryoballoon ablation alone and with additional isolation of the superior vena cava in patients with persistent atrial fibrillation

Aim. To study the impact and safety of cryoballoon ablation of the pulmonary vein (PV), supplemented by isolation of the superior vena cava in patients with persistent atrial fibrillation (AF).

Methods. The study is single-center, randomized, prospective. The total number of patients was 40. All of them underwent cryoballoon isolation of the PV for persistent AF. The patients were then divided into two groups: the first group included patients who underwent the standard procedure, and the second group included patients with the standard procedure supplemented by isolation of the superior vena cava. Patients in both groups had similar anatomical and clinical-anamnestic parameters. The duration of the surgical intervention was not statistically different.

Results. The average follow-up period was 354±19 days. In the group of classical cryoballoon PV isolation, after 12 months of observation without antiarrhythmic therapy, sinus rhythm was maintained in 40% of patients (8 people), in the group of extended cryoballoon PV isolation - in the same number of patients (40%, P=1). In the PV isolation group, persistent phrenic nerve palsy was observed in no patients, and in the extended ablation group, in eight patients (40%, P=0.0016). At the end of the observation, no remote complications were registered.

Conclusions. In patients with persistent AF, cryoballoon PV isolation supplemented by superior vena cava isolation is a less safe technique than standard cryoballoon pulmonary vein isolation, with comparable efficacy.

1. Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989): 154-62. http://doi.org/10.1016/s0140-6736(14)61774-8.

2. Calkins H, Reynolds MR, Spector P, et al. Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation. Circulation: Arrhythmia and Electrophysiology. 2009;2(4): 349-61. http://doi.org/10.1161/circep.108.824789.

3. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2021;42(40): 4194-4194. http://doi.org/10.1093/eurheartj/ehab648.

4. Andrade JG, Deyell MW, Badra M, et al. Randomised clinical trial of cryoballoon versus irrigated radio frequency catheter ablation for atrial fibrillation-the effect of double short versus standard exposure cryoablation duration during pulmonary vein isolation (CIRCA-DOSE): methods and rationale. BMJ Open. 2017;7(10): e017970. http://doi.org/10.1136/bmjopen-2017-017970.

5. Della Rocca DG, Marcon L, Magnocavallo M, et al. Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison. Europace. 2023;26(1). http://doi.org/10.1093/europace/euae016.

6. Lin CY, Lin YJ, Higa S, et al. Catheter Ablation With Morphologic Repetitiveness Mapping for Persistent Atrial Fibrillation. JAMA Network Open. 2023;6(11): e2344535. http://doi.org/10.1001/jamanetworkopen.2023.44535.

7. William J, Chieng D, Sugumar H, et al. The Role of Posterior Wall Isolation in Catheter Ablation for Persistent Atrial Fibrillation and Systolic Heart Failure. JAMA Cardiology. 2023;8(11): 1077. http://doi.org/10.1001/jamacardio.2023.3208.

8. Wijesurendra RS, Casadei B. Mechanisms of atrial fibrillation. Heart. 2019;105(24): 1860-7. http://doi.org/10.1136/heartjnl-2018-314267.

9. Revishvili ASh, Popov VA, Aminov VV, et al. Surgical treatment of paroxysmal atrial fibrillation concomitant to coronary artery bypass grafting: pulmonary vein isolation or maze V? Complex Issues of Cardiovascular Diseases. 2022;11(4): 47-61. (In Russ.) https://doi.org/10.17802/2306-1278-2022-11-4-47-61.

10. Miyazaki S, Takigawa M, Kusa S, et al. Role of Arrhythmogenic Superior Vena Cava on Atrial Fibrillation. Journal of Cardiovascular Electrophysiology. 2014;25(4): 380-6. http://doi.org/10.1111/jce.12342.

11. Goyal R, Gracia E, Fan R. The Role of Superior Vena Cava Isolation in the Management of Atrial Fibrillation. Journal of Innovations in Cardiac Rhythm Management. 2017;8(4): 2674-80. http://doi.org/10.19102/icrm.2017.080406.

12. Saharchuk TV. Structure Organization Of The Area Of Orifices Of Cava Veins In The Human Embryogenesis. Health and Ecology Issues. 2008;(3): 76-80. (In Russ.) https://doi.org/10.51523/2708-6011.2008-5-3-15.

13. Kholova I, Kautzner J. Morphology of Atrial Myocardial Extensions Into Human Caval Veins. Circulation. 2004;110(5): 483-8. http://doi.org/10.1161/01.cir.0000137117.87589.88.

14. Filatov AG, Kovalev AS. The role of radiofrequency isolation of superior vena cava in patients with atrial fibrillation. Russian Annals of Surgery. 2019;24(3): 159-64. (In Russ.) https://doi.org/10.24022/1560-9502-2019-24-3-159-164.

15. Andrade JG, Deyell MW, Verma A, et al. The Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) Study Results in Context. Electrophysiology Review. 2020;9(1): 34-9. http://doi.org/10.15420/aer.2019.13.

16. Victor C. Superior vena CAVA Isolation by Cryoballoon in Addition to Pulmonary Vein Isolation in Atrial Fibrillation Ablation Patients. A Randomized Trial. CAVAC AF Trial. Study Rationale and Design. Journal of Atrial Fibrillation and Electrophysiology. 2022;15(1). http://doi.org/10.4022/jafib.20200510.

17. Iacopino S, Osório TG, Filannino P, et al. Safety and feasibility of electrical isolation of the superior vena cava in addition to pulmonary vein ablation for paroxysmal atrial fibrillation using the cryoballoon: lessons from a prospective study. Journal of Interventional Cardiac Electrophysiology. 2020;60(2): 255-60. http://doi.org/10.1007/s10840-020-00740-y.

18. Dubuc M, Roy D, Thibault B, al. Transvenous Catheter Ice Mapping and Cryoablation of the Atrioventricular Node in Dogs. Pacing and Clinical Electrophysiology. 1999;22(10): 1488-98. http://doi.org/10.1111/j.1540-8159.1999.tb00353.x.

19. Wei H, Guo X, Sun Q, et al. Electrical isolation of the superior vena cava using second‐generation cryoballoon in patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2020;31(6): 1307-14. http://doi.org/10.1111/jce.14477.

20. Chen CK, Yu CC. Effective superior vena cava isolation using a novel C-shaped approach. Frontiers in Cardiovascular Medicine. 2023;10. http://doi.org/10.3389/fcvm.2023.1253912.

21. Mol D, Renskers L, Balt JC, et al. Persistent phrenic nerve palsy after atrial fibrillation ablation: Follow‐up data from The Netherlands Heart Registration. Journal of Cardiovascular Electrophysiology. 2022 Jan 28;33(3):559-64. http://doi.org/10.1111/jce.15368.

22. Miyazaki S, Usui E, Kusa S, et al. Prevalence and clinical outcome of phrenic nerve injury during superior vena cava isolation and circumferential pulmonary vein antrum isolation using radiofrequency energy. American Heart Journal. 2014 Dec;168(6):846-53. http://doi.org/10.1016/j.ahj.2014.09.011.

23. Ollitrault P, Chaumont C, Font J, et al. Superior vena cava isolation using a pentaspline pulsed-field ablation catheter: feasibility and safety in patients undergoing atrial fibrillation catheter ablation. Europace. 2024;26(7). http://doi.org/10.1093/europace/euae160.